BACKGROUND: Neuroendocrine (NE) differentiation may be related to the growth and progression of prostate cancer, especially androgen-insensitive tumors. Recently the over-expression of a new anti-apoptosis protein, survivin, has attracted attention for its potential implication in many human cancers. The fact that NE cells in prostate are bcl-2 negative prompted us to investigate if the prostatic NE cells over-express survivin. METHODS: Double immunohistochemical staining and immunofluorescence of chromogranin A (CgA) and survivin were performed in 57 patients with localized prostate cancer who underwent radical prostatectomy. The terminal deoxynucleotidyl transferase (TDT)-mediated dUTP-digoxigenin nick end-labeling (TUNEL) method was used...
2012-09-13Our study of prostate cancer is centered on a conditional mouse model based on the Cre/lox...
International audienceAim: In prostate cancer (PCa), neuroendocrine differentiation (NED) is commonl...
Hormone refractory prostate cancer occurs when androgen-deprivation therapy (ADT) fails to stop the ...
BACKGROUND: Neuroendocrine (NE) differentiation may be related to the growth and progression of pros...
Benign prostate contains luminal epithelial cells, basal cells and a minor component of neuroendocri...
Neuroendocrine differentiation in prostatic carcinoma has been related to regulation of proliferatio...
BACKGROUND: In the prostate, the importance of sex hormones for its normal development and function ...
Neuroendocrine differentiation (NED) secondary to androgen deprivation therapy (ADT) may be frequent...
In this review, we will present some of the information that is known about neuroendocrine (NE) cell...
The inhibitor of apoptosis protein survivin is expressed in most cancers. Using the conditional PTEN...
AbstractThe neuroendocrine (NE) cell is a minor cell population in normal human prostate glands. The...
Abstract Background Survivin is a member of the inhibitor-of-apoptosis (IAP) family which is widely ...
The neuroendocrine (NE) cell is a minor cell population in normal human prostate glands. The number ...
Objectives: This review aims to provide practising clinicians with the most recent knowledge of the ...
Survivin is an Inhibitor of Apoptosis Protein (IAP), which makes it responsible for cell proliferati...
2012-09-13Our study of prostate cancer is centered on a conditional mouse model based on the Cre/lox...
International audienceAim: In prostate cancer (PCa), neuroendocrine differentiation (NED) is commonl...
Hormone refractory prostate cancer occurs when androgen-deprivation therapy (ADT) fails to stop the ...
BACKGROUND: Neuroendocrine (NE) differentiation may be related to the growth and progression of pros...
Benign prostate contains luminal epithelial cells, basal cells and a minor component of neuroendocri...
Neuroendocrine differentiation in prostatic carcinoma has been related to regulation of proliferatio...
BACKGROUND: In the prostate, the importance of sex hormones for its normal development and function ...
Neuroendocrine differentiation (NED) secondary to androgen deprivation therapy (ADT) may be frequent...
In this review, we will present some of the information that is known about neuroendocrine (NE) cell...
The inhibitor of apoptosis protein survivin is expressed in most cancers. Using the conditional PTEN...
AbstractThe neuroendocrine (NE) cell is a minor cell population in normal human prostate glands. The...
Abstract Background Survivin is a member of the inhibitor-of-apoptosis (IAP) family which is widely ...
The neuroendocrine (NE) cell is a minor cell population in normal human prostate glands. The number ...
Objectives: This review aims to provide practising clinicians with the most recent knowledge of the ...
Survivin is an Inhibitor of Apoptosis Protein (IAP), which makes it responsible for cell proliferati...
2012-09-13Our study of prostate cancer is centered on a conditional mouse model based on the Cre/lox...
International audienceAim: In prostate cancer (PCa), neuroendocrine differentiation (NED) is commonl...
Hormone refractory prostate cancer occurs when androgen-deprivation therapy (ADT) fails to stop the ...